Lack of survival advantage with autologous stem-cell transplantation in high-risk neuroblastoma consolidated by anti-G(D2) immunotherapy and isotretinoin

Since 2003, high-risk neuroblastoma (HR-NB) patients at our center received anti-G(D2) antibody 3F8/GM-CSF + isotretinoin – but not myeloablative therapy with autologous stem-cell transplantation (ASCT). Post-ASCT patients referred from elsewhere also received 3F8/GM-CSF + isotretinoin. We therefore...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Oncotarget
Hauptverfasser: Kushner, Brian H., Ostrovnaya, Irina, Cheung, Irene Y., Kuk, Deborah, Modak, Shakeel, Kramer, Kim, Roberts, Stephen S., Basu, Ellen M., Yataghene, Karima, Cheung, Nai-Kong V.
Format: Artigo
Sprache:Inglês
Veröffentlicht: Impact Journals LLC 2015
Schlagworte:
Research Paper
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4826196/
https://ncbi.nlm.nih.gov/pubmed/26623730
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.6393
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge